This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

2013 US Clinical Chemistry And Immunodiagnostics Markets

NEW YORK, Jan. 4, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

2013 US Clinical Chemistry and Immunodiagnostics Markets

http://www.reportlinker.com/p01079323/2013-US-Clinical-Chemistry-and-Immunodiagnostics-Markets.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

This new report from Venture Planning Group contains 600 pages, 120 tables and presents a comprehensive analysis of the US clinical chemistry and immunodiagnostics markets, including:

  • Major issues pertaining to the US clinical chemistry and immunodiagnostic laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
  • Five- and ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in US hospitals, commercial laboratories, and physician offices, including controls, calibrators and consumables.
  • Five- and ten-year volume forecasts for serum, whole blood, plasma, CFS, urine and other specimens.
  • Five- and ten-year reagent and instrument sales forecasts.
  • Review of current instrumentation technologies, and a feature comparison of 50 high-, medium-, and low-volume/POC analyzers.
  • Sales and market shares of leading reagent and instrument suppliers.
  • Review of current and emerging technologies and their potential market applications.
  • Product development opportunities for clinical chemistry and immunodiagnostic instruments and consumables.
  • Profiles of 25 current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
  • Market penetration strategies, entry barriers and risks.

Contains 600 pages and 120 tables

Table of Contents

Introduction

Worldwide Market and Technology Overview

A. Major Routine Chemistry Tests

1. Albumin

2. Alkaline Phosphatase

3. ALT/SGPT

4. Ammonia

5. Amylase

6. AST/SGOT

7. Bilirubin, Total

8. Blood Gases

9. Blood Urea Nitrogen (BUN)

10. Calcium

11. Cardio CRP

12. Cholesterol

13. Cholinesterase

14. CRP

15. Creatinine

16. Electrolytes

a. Carbon Dioxide/Bicarbonate

1 of 8

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
SYM TRADE IT LAST %CHG

Markets

DOW 18,285.74 +0.34 0.00%
S&P 500 2,130.82 +4.97 0.23%
NASDAQ 5,090.7940 +19.0510 0.38%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs